valproic acid has been researched along with propranolol in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (12.86) | 18.7374 |
1990's | 2 (2.86) | 18.2507 |
2000's | 23 (32.86) | 29.6817 |
2010's | 30 (42.86) | 24.3611 |
2020's | 6 (8.57) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Jolivette, LJ; Ward, KW | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chatzopoulou, M; Demopoulos, VJ; Kristl, A; Patsilinakos, A; Prnova, MS; Ragno, R; Stefek, M; Tsantili-Kakoulidou, A; Vallianatou, T; Zakelj, S | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Budziszewska, B; Koczurkiewicz, P; Marona, H; Pańczyk, K; Pękala, E; Piska, K; Pytka, K; Rapacz, A; Starek-Świechowicz, B; Waszkielewicz, AM | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Gourmel, B; Nataf, N; Rossignol, P | 1 |
Lerer, B | 1 |
Hanano, M; Iga, T; Sawada, Y; Sugiyama, Y | 1 |
Emrich, HM; von Zerssen, D | 1 |
Bauman, AW; Hammond, EJ; Karas, BJ; Wilder, BJ | 1 |
Müller, FO; Steyn, JM | 1 |
Emrich, HM; Kissling, W; Möller, HJ; von Zerssen, D; Windorfer, A | 1 |
Cramer, JA; Mattson, RH | 1 |
Kaniecki, RG | 1 |
Chronicle, EP; Mulleners, WM; Palmer, JE; Rolan, P | 1 |
Evers, S; Gerber, WD; Naumann, E; Pothmann, R; Uberall, M | 1 |
De Sarro, A; De Sarro, G; Di Paola, ED; Ferreri, G; Fischer, W | 1 |
Mayer, J; McDiarmid, T; Spry, H; Stanton, RN | 1 |
Mannix, LK | 1 |
Evans, RW; Láinez, MJ; Leira, R; Pascual, J | 1 |
Raskind, MA; Rosin, RA | 1 |
Ashrafi, MR; Mahfelati, F; Shabanian, R; Zamani, GR | 1 |
Dainese, F; Maggioni, F; Mainardi, F; Ruffatti, S; Zanchin, G | 1 |
Kawasaki, A; Purvin, VA; Williams, PE | 1 |
Quimbo, RM; Rupnow, MF; Wertz, DA; Yaldo, AZ | 1 |
Abolfazl, MB; Keyvan, G | 1 |
Bidabadi, E; Mashouf, M | 1 |
Aydin, M; Bozdag, S; Ertugrul, S; Kabakus, N | 1 |
Li, Q; Tan, G; Zhou, J | 1 |
Chronicle, EP; Linde, M; McCrory, DC; Mulleners, WM | 1 |
Charles, A; McGuire, B; Pradhan, AA; Tarash, I; Tipton, AF | 1 |
Ak, S; Atasayar, G; Can, FE; Cecener, G; Egeli, U; Eryilmaz, IE; Karli, N; Taskapilioglu, O; Tezcan, G; Tunca, B; Yildirim, O; Zarifoglu, M | 1 |
Barchukov, VG; Kundashev, UK; Morozov, IS; Salenko, YA; Zurdinov, AZ | 1 |
Golding, AN; Houle, TT; Turner, DP | 1 |
He, A; Li, C; Song, D; Zhang, L | 1 |
Abe, K; Hashimura, M; Iha, HA; Iwai, C; Kato, M; Kawaji, S; Kawakita, K; Kunisawa, N; Ogawa, M; Ohno, Y; Shimizu, S | 1 |
Hayashino, Y; Jackson, JL; Jackson, W; Kuriyama, A; Kuwatsuka, Y; Nickoloff, S; Storch, D; Zhang, ZJ | 1 |
Arvaniti, C; Constantinidis, TS; Fakas, N; Giannouli, E; Kalamatas, T; Kararizou, E; Kouremenos, E; Mitsikostas, DD; Naoumis, D | 1 |
Branch, S; Gaki, E; Morgan, S; Siapkara, A | 1 |
Edem, P; Günay, Ç; Hız-Kurul, AS; Yaşar, E; Yiş, U | 1 |
Akbari, Z; Ardestani, PM; Gholampour, M; Kouhanjani, MF; Nemati, H; Sarvipour, N; Shafie'ei, M; Shekouh, D | 1 |
Ahmadzadeh, S; Bocklud, BE; Corley, SC; Granier, MA; Ingram, EE; Kaye, AD; Neuchat, EE; Shekoohi, S | 1 |
Chen, JJ; Chen, TY; Chen, YW; Hsu, CW; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC; Zeng, BS; Zeng, BY | 1 |
14 review(s) available for valproic acid and propranolol
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Alternative therapies for bipolar disorder.
Topics: Ascorbic Acid; Bipolar Disorder; Bupropion; Carbamazepine; Choline; Clonazepam; Clonidine; Clorgyline; Demeclocycline; Fenfluramine; Humans; Methylene Blue; Phosphatidylcholines; Physostigmine; Propiophenones; Propranolol; Spironolactone; Thyroxine; Tryptophan; Valproic Acid | 1985 |
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Topics: Animals; Antipyrine; Barbiturates; Biological Availability; Chlorpromazine; Diazepam; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Pentazocine; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Propranolol; Quinidine; Rats; Species Specificity; Tissue Distribution; Tolbutamide; Valproic Acid; Warfarin | 1985 |
[Treatment of idiopathic headache in childhood - recommendations of the German Migraine and Headache Society (DMKG)].
Topics: Acetaminophen; Adrenergic beta-Antagonists; Age Factors; Analgesics, Non-Narcotic; Biofeedback, Psychology; Child; Flunarizine; GABA Agents; Headache; Humans; Ibuprofen; Metoprolol; Migraine Disorders; Practice Guidelines as Topic; Propranolol; Relaxation Therapy; Serotonin Receptor Agonists; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents | 2002 |
Clinical inquiries. What medication best prevents migraine in children?
Topics: Amitriptyline; Child; Evidence-Based Medicine; Humans; Migraine Disorders; Propranolol; Valproic Acid | 2003 |
Clinical advances in the preventive treatment of migraine.
Topics: Amitriptyline; Fructose; Humans; Migraine Disorders; Propranolol; Topiramate; Valproic Acid | 2004 |
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
Topics: Adult; Anticonvulsants; Flunarizine; Fructose; Humans; Migraine Disorders; Propranolol; Randomized Controlled Trials as Topic; Topiramate; Valproic Acid | 2013 |
Prevention of migraine attacks. First-choice treatments.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Analgesics; Anticonvulsants; Antidepressive Agents, Tricyclic; Female; Humans; Migraine Disorders; Pregnancy; Pregnancy Complications; Propranolol; Risk Factors; Risk Reduction Behavior; Treatment Outcome; Valproic Acid | 2015 |
Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
Topics: Adult; Amines; Amitriptyline; Anticonvulsants; Cyclohexanecarboxylic Acids; Dizziness; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Migraine Disorders; Nausea; Pre-Exposure Prophylaxis; Propranolol; Randomized Controlled Trials as Topic; Topiramate; Treatment Outcome; Valproic Acid | 2017 |
Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Female; Humans; Male; Migraine Disorders; Propranolol; Tension-Type Headache; Topiramate; Valproic Acid | 2019 |
Application of cinnarizine in migraine prevention: A systematic review and meta-analysis.
Topics: Activities of Daily Living; Cinnarizine; Humans; Migraine Disorders; Propranolol; Quality of Life; Valproic Acid | 2022 |
Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Calcium Channel Blockers; Drug-Related Side Effects and Adverse Reactions; Humans; Migraine Disorders; Propranolol; Serotonin 5-HT1 Receptor Agonists; Topiramate; Tryptamines; Valproic Acid | 2023 |
Network Meta-analysis of Different Treatments for Vestibular Migraine.
Topics: Adult; Female; Humans; Male; Migraine Disorders; Network Meta-Analysis; Propranolol; Valproic Acid; Venlafaxine Hydrochloride | 2023 |
7 trial(s) available for valproic acid and propranolol
Article | Year |
---|---|
Treatment of valproate tremors.
Topics: Amantadine; Cyproheptadine; Diphenhydramine; Humans; Propranolol; Tremor; Valproic Acid | 1983 |
Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Alcohol Withdrawal Delirium; Bipolar Disorder; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Lithium; Male; Middle Aged; Placebos; Propranolol; Valproic Acid | 1980 |
A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Cross-Over Studies; Female; GABA Agents; Humans; Male; Middle Aged; Migraine Disorders; Placebos; Propranolol; Sensation Disorders; Single-Blind Method; Treatment Outcome; Valproic Acid | 1997 |
Sodium Valproate versus Propranolol in paediatric migraine prophylaxis.
Topics: Adolescent; Adrenergic beta-Antagonists; Anticonvulsants; Child; Child, Preschool; Humans; Incidence; Migraine Disorders; Propranolol; Severity of Illness Index; Time Factors; Treatment Outcome; Valproic Acid | 2005 |
Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up.
Topics: Adrenergic beta-Antagonists; Adult; Amines; Amitriptyline; Analgesics, Non-Narcotic; Anticonvulsants; Atenolol; Cyclohexanecarboxylic Acids; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Pizotyline; Propranolol; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil; Weight Gain | 2005 |
Comparison of treatment effect of sodium valproate, propranolol and tricyclic antidepressants in migraine.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Humans; Migraine Disorders; Propranolol; Treatment Outcome; Valproic Acid; Vasodilator Agents | 2009 |
A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Topics: Adolescent; Child; Child, Preschool; Humans; Migraine Disorders; Propranolol; Time Factors; Valproic Acid | 2010 |
49 other study(ies) available for valproic acid and propranolol
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Decreasing acidity in a series of aldose reductase inhibitors: 2-Fluoro-4-(1H-pyrrol-1-yl)phenol as a scaffold for improved membrane permeation.
Topics: Aldehyde Reductase; Animals; Cell Membrane Permeability; Dose-Response Relationship, Drug; Enzyme Inhibitors; Jejunum; Lenses; Male; Models, Molecular; Molecular Structure; Phenols; Pyrroles; Rats; Rats, Wistar; Sorbitol; Structure-Activity Relationship | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Design, synthesis and anticonvulsant-analgesic activity of new
Topics: | 2017 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Pharmacological actions on hypoxic increase of rat brain cortex extracellular K+ ion.
Topics: Animals; Cerebral Cortex; Extracellular Space; Hypoxia; Male; Phenytoin; Potassium; Propranolol; Pyrithioxin; Rats; Stereoisomerism; Valproic Acid; Vincamine | 1978 |
New drugs for mania?
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Humans; Propranolol; Psychotic Disorders; Valproic Acid | 1983 |
Comparative effects of two commercially available blood collection tubes on plasma concentrations of drugs.
Topics: Acebutolol; Blood Specimen Collection; Carbamazepine; Diazepam; Digoxin; Ethosuximide; Humans; Nordazepam; Penbutolol; Pharmaceutical Preparations; Propranolol; Quinidine; Salicylates; Time Factors; Valproic Acid; Warfarin | 1980 |
Tremor due to sodium valproate.
Topics: Humans; Propranolol; Tremor; Valproic Acid | 1981 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients.
Topics: Adult; Aged; Analgesics; Cortical Spreading Depression; Female; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Migraine with Aura; Perceptual Masking; Photic Stimulation; Pizotyline; Propranolol; Valproic Acid; Visual Cortex | 2000 |
Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Topics: Acoustic Stimulation; Adrenergic beta-Antagonists; Animals; Anticonvulsants; Atenolol; Body Temperature; Carbamazepine; Epilepsy, Reflex; Female; Lamotrigine; Male; Metoprolol; Mice; Mice, Inbred DBA; Motor Activity; Phenobarbital; Propanolamines; Propranolol; Stereoisomerism; Triazines; Valproic Acid | 2002 |
Bending the rule of monotherapy for migraine prevention?
Topics: Adrenergic beta-Antagonists; Adult; Amitriptyline; Drug Therapy, Combination; Female; Humans; Migraine Disorders; Propranolol; Valproic Acid | 2005 |
Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report.
Topics: Aged; Aggression; Alzheimer Disease; Amines; Antipsychotic Agents; Benzodiazepines; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Gabapentin; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Olanzapine; Propranolol; Quetiapine Fumarate; Risperidone; Testosterone; Trazodone; Treatment Outcome; Valproic Acid | 2005 |
Pharmacological prevention of migraine: to be considered case by case.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anticonvulsants; Antidepressive Agents; Cost-Benefit Analysis; Flunarizine; France; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol; Serotonin Antagonists; United Kingdom; Valproic Acid | 2006 |
Superior oblique myokymia: efficacy of medical treatment.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Diplopia; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Optical Illusions; Phenytoin; Propranolol; Retrospective Studies; Treatment Outcome; Trochlear Nerve Diseases; Valproic Acid | 2007 |
Psychopharmacology news. New side effects of agents.
Topics: Benzodiazepines; Bupropion; Female; Humans; Olanzapine; Pregnancy; Propranolol; Psychotropic Drugs; Valproic Acid | 2007 |
Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
Topics: Adult; Age Factors; Amitriptyline; Cohort Studies; Databases, Factual; Dose-Response Relationship, Drug; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Fructose; Humans; Kaplan-Meier Estimate; Male; Managed Care Programs; Medication Adherence; Middle Aged; Migraine Disorders; Proportional Hazards Models; Propranolol; Retrospective Studies; Sex Factors; Time Factors; Timolol; Topiramate; Valproic Acid | 2008 |
Profile of children with migraine.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Flunarizine; Fructose; Humans; Male; Migraine Disorders; Prevalence; Propranolol; Risk Factors; Topiramate; Turkey; Valproic Acid; Vasodilator Agents | 2010 |
Basilar-type migraine with coma: case reports and literature review.
Topics: Adolescent; Anticonvulsants; Antihypertensive Agents; Asian People; Coma; Female; Humans; Male; Migraine with Aura; Propranolol; Treatment Outcome; Valproic Acid | 2011 |
Drugs to prevent migraines are underused.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Fructose; Humans; Migraine Disorders; Preventive Health Services; Propranolol; Timolol; Treatment Outcome; United States; Valproic Acid | 2012 |
The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.
Topics: Acute Disease; Amiloride; Animals; Anticonvulsants; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Male; Mice; Migraine Disorders; Nitroglycerin; Pain Measurement; Propranolol; Serotonin 5-HT1 Receptor Agonists; Species Specificity; Sumatriptan; Treatment Outcome; Valproic Acid; Vasodilator Agents | 2016 |
Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.
Topics: Adult; Amitriptyline; ATP Binding Cassette Transporter, Subfamily B; Central Nervous System Agents; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Resistance; Female; Fructose; Gene Frequency; Genetic Association Studies; Humans; Male; Migraine Disorders; Polymorphism, Genetic; Propranolol; Risk Factors; Topiramate; Treatment Outcome; Valproic Acid | 2016 |
[EFFECT OF MEDIATOR-TYPE DRUGS ON HUMAN PSYCHOPHYSIOLOGICAL STATUS DURING MODEL OPERATOR ACTIVITY].
Topics: Adult; Anabasine; Attention; Belladonna Alkaloids; Benzodiazepines; Central Nervous System Stimulants; Dioxanes; Double-Blind Method; Haloperidol; Humans; Isoproterenol; Male; Propranolol; Psychophysiology; Sydnones; Task Performance and Analysis; Tranquilizing Agents; Valproic Acid; Yohimbine | 2016 |
Using a graphical risk tool to examine willingness to take migraine prophylactic medications.
Topics: Amines; Analgesics; Antidepressive Agents; Antihypertensive Agents; Cross-Sectional Studies; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Headache; Humans; Longitudinal Studies; Male; Migraine Disorders; Pain Measurement; Pre-Exposure Prophylaxis; Propranolol; Retrospective Studies; Surveys and Questionnaires; Valproic Acid; Venlafaxine Hydrochloride | 2016 |
Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents.
Topics: Animals; Anticonvulsants; Antiparkinson Agents; Benzeneacetamides; Calcium Channel Blockers; Carbamazepine; Diazepam; Disease Models, Animal; Essential Tremor; Ethosuximide; Male; Mice, Inbred Strains; Nicotine; Phenobarbital; Propranolol; Pyridines; Valproic Acid | 2018 |
Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Botulinum Toxins, Type A; Consensus; Greece; Humans; Migraine Disorders; Propranolol; Societies, Medical; Treatment Outcome; Tryptamines; Valproic Acid | 2019 |
Sodium valproate in paediatric migraine.
Topics: Child; Cinnarizine; Double-Blind Method; Humans; Migraine Disorders; Propranolol; Valproic Acid | 2020 |
Recurrent painful ophthalmoplegic neuropathy: a report of two new pediatric cases.
Topics: Child; Child, Preschool; Female; Headache; Humans; Magnetic Resonance Imaging; Ophthalmoplegia; Ophthalmoplegic Migraine; Pain; Peripheral Nervous System Diseases; Propranolol; Tolosa-Hunt Syndrome; Valproic Acid | 2022 |